Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

CCBR Clinical Research (Now Bioclinica)CCBR Clinical Research (Now Bioclinica)
VS
MSDMSD
CCBR Clinical Research (Now Bioclinica)

CCBR Clinical Research (Now Bioclinica)

N/A

Last Update: 01/01/2026

View Profile

CCBR is now Bioclinica. Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized by three business segments to deliver focused service supporting multifaceted technologi...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:104
Subsidiaries:4
12-month incidents
0
Known data breaches
0
Attack type number
0
MSD

MSD

90 E Scott Ave, Rahway, 07065, US

Last Update: 07/09/2026

View Profile
Between 750 and 799
http://www.msd.com
771/1000Fair

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:39,710
Subsidiaries:39
12-month incidents
0
Known data breaches
1
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
CCBR Clinical Research (Now Bioclinica)

CCBR Clinical Research (Now Bioclinica)

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MSD

MSD

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for CCBR Clinical Research (Now Bioclinica) in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD in 2026.

Incidents

Incident History - CCBR Clinical Research (Now Bioclinica) (X = Date, Y = Severity)

CCBR Clinical Research (Now Bioclinica) cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MSD (X = Date, Y = Severity)

MSD cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
CCBR Clinical Research (Now Bioclinica)

CCBR Clinical Research (Now Bioclinica)

Incidents
No explicit notable incidents reported.
MSD

MSD

Incidents
🔒 Incident : Breach
MSD0602706111825

FAQ

Between CCBR Clinical Research (Now Bioclinica) company and MSD company, which one has the best AI Cybersecurity Score ?
Between CCBR Clinical Research (Now Bioclinica) company and MSD company, which one has experienced more cyber incidents in the past ?
Between CCBR Clinical Research (Now Bioclinica) company and MSD company, which one has experienced more cyber incidents this year ?
Between CCBR Clinical Research (Now Bioclinica) company and MSD company, which one has experienced at least one ransomware attack ?
Between CCBR Clinical Research (Now Bioclinica) company and MSD company, which one has experienced at least one data breach ?
Between CCBR Clinical Research (Now Bioclinica) company and MSD company, which one has experienced at least one targeted cyberattack ?
Between CCBR Clinical Research (Now Bioclinica) company and MSD company, which one has experienced at least one vulnerability ?
Between CCBR Clinical Research (Now Bioclinica) company and MSD company, which one holds the most compliance certifications ?
Between CCBR Clinical Research (Now Bioclinica) company and MSD company, which one holds the fewest compliance certifications ?
Between CCBR Clinical Research (Now Bioclinica) company and MSD company, which one has the most subsidiaries ?
Between CCBR Clinical Research (Now Bioclinica) company and MSD company, which one has the largest number of employees ?
Between CCBR Clinical Research (Now Bioclinica) and MSD, which company holds both SOC 2 Type 1 certifications ?
Between CCBR Clinical Research (Now Bioclinica) and MSD, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - CCBR Clinical Research (Now Bioclinica) or MSD ?
Which company is PCI DSS compliant - CCBR Clinical Research (Now Bioclinica) or MSD ?
Between CCBR Clinical Research (Now Bioclinica) and MSD, which company complies with HIPAA regulations for healthcare data ?
Between CCBR Clinical Research (Now Bioclinica) and MSD, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-91201
SUMMARY

DocsGPT through 0.20.0 posts OAuth connector session tokens to a wildcard target origin in the callback-status endpoint without validating sender origin. Attackers can obtain session tokens and provider account emails by acting as window.opener during OAuth authorization, then use tokens to disconnect victims' cloud storage connectors.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
2.5
EXPLOITABILITY
2.8
CVE-2026-91200
SUMMARY

DevSpace through 6.3.21 fails to reject parent-directory segments in tar entry names from the in-pod sync stream. Attackers operating a malicious container can stream tar entries with traversal sequences to write arbitrary files on the developer workstation, enabling code execution.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-91199
SUMMARY

Refly through 1.1.0 contains a server-side request forgery vulnerability in the POST /v1/misc/scrape endpoint that fetches caller-supplied URLs without validating the scheme, host, or resolved address. Authenticated attackers can make the backend issue requests to loopback, private, and link-local addresses including cloud metadata services to read page titles and descriptions of internal resources.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 5)
CVSS3
Base Score: 5.0
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.1
CVE-2026-91198
SUMMARY

GrowthBook through 5.0.1 returns unredacted fact table definitions including raw warehouse SQL in payloads served by unauthenticated public report and experiment endpoints. Attackers with knowledge of a publicly shared report or experiment identifier can read internal data warehouse query text, schema, table names, filter values and datasource identifiers.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 5.3)
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-91197
SUMMARY

Flowable flowable-engine through 8.0.0 contains an XML external entity injection vulnerability in ProcessDiagramLayoutFactory.parseXml() that fails to disable external entity resolution when parsing deployed BPMN resources. Attackers with process deployment privileges can embed DOCTYPE declarations with external entities in BPMN files to read arbitrary local files or trigger requests to internal network endpoints when diagram layout is computed.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8